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It has been for many decades a dogma in immunology that only substances of rela- 
tively high molecular weight are able to function as complete immunogens and to in- 
duce the formation of antibodies  and/or delayed hypersensitivity  (1). Compounds of 
low molecular weight and simple sensitizing chemicals (2) have been considered hap- 
tens, only able to become immunogenic when covalenfly bound to some large molecular 
weight protein carrier. For quite a while the size limit ascribed to immunogenic mole- 
cules was 10,000 (3). However, more recent  studies  on the immunogenicity  of oligo- 
peptides  have indicated  that compounds with a molecular weight as low as 4000 may 
also be immunogenlc  (4). Furthermore,  reports  from several groups of workers have 
indicated that even smaller molecules, i.e. hapten-amino acids or hapten-oligopeptides, 
may behave as immtmogens. The first  published  report on the immunogenicity  of 
hapten-amino acids appears  to be that of Jansen,  Berrens, and van Delden  (5), who 
described the induction of contact dermatitis  to dinitrochlorobenzene in pigs by injec- 
tion of a mixture  of diultrophenyl  amino acids. We observed independently  a similar 
phenomenon in guinea pigs and reported  some preliminary  data in 1966 (6). Further- 
more,  the immunogenicity  of hapten-amino acids has been reported with the p-azo- 
benzenearsonate  hapten by Leskowitz  and his collaborators  (7)  and by Borek  and 
coworkers (8). However,  before accepting  at face value  the contention  that hapten- 
amino  acids are effective immunogens, previous  negative  results  (9)  should  also be 
remembered. 
The finding that some hapten-amino  acid compounds do induce contact sensitization 
and the formation of anti-hapten antibodies is of both theoretical  and practical  inter- 
est. The possibility  that simple hapten-amino  acid conjugates may behave as immuno- 
gens would open new perspectives  in the understanding  of contact sensitization  and 
drug allergy in man. Furthermore,  hapten-amino  acids might prove to be very suitable 
substances for studying the biochemical pathways responsible for the induction  of the 
immune response. 
The purpose of this investigation was to establish in a quantitative and con- 
trolled manner a catalogue of DNP-amino acids  1 capable of inducing an immune 
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response in guinea pigs and/or rabbits. Among 35 DNP-a~ino  acids or DNP 
derivatives we tested, 24 were found to induce delayed and/or immediate type 
hypersensitivity of DNP  specificity. However, we had to ascertain that these 
responses were indeed due to the DNP-amino acid itself and not, for instance, 
to  highly  immunogenic  chemical  impurities  such  as  dinitrofluorobenzene. 
Extensive chemical and chromatographic analysis of all DNP-amino acid prep- 
arations tested left no doubt that several preparations, in which no impurities 
could be detected at all, were still immunogenic.  On  the other hand,  various 
lots of the same preparation (which were  analytically indistinguishable)  had 
strikingly different immunological properties. Whereas the immunogenicity of 
DNP-amino acids as such could not be entirely excluded in all cases, it appears 
from our experiments that the immunogenic effect is due either to very minute 
amounts  of immunogenic impurities or to  a  "transconjugation"  of the DNP 
group,  which  is  able  to  split  from  its  amino  acid  carrier  and  to  conjugate 
secondarily to available protein carriers. 
Materials and Methods 
DiniLrophcnyl Reagents.--2,4-Dinitrochlorobenzene (Merck, Darmstadt, Germany), 2,4- 
dinitrofluorobenzene  (Roche,  Basle,  Switzerland), 2,4-dinitrophenol and 2,4-dinitrophenyl- 
aniline (Fluka, Buchs, Switzerland), and 2,4-dinitrobenzenesnlfonlc  acid sodium salt (Eastman 
Kodak, Rochester,  N.Y.) were all of the purest available reagent grade. 2,4-Dinitrophenyl- 
amino acids and related compounds were purchased from various manufacturers (Mann, Re- 
search Laboratories, New York, N.Y., British Drug Houses, London, England; Sigma Chem- 
cal Co., St. Louis, MoO and were of the purest grade available (for chromatographic stand- 
ards).  Other  preparations were  synthesized in  the  chemical laboratories of Hoffman-I,a 
Roche, Ltd., according to the procedures described by Porter and Sanger (10). All compounds 
tested, and their manufacturers, are listed in Table I. Unless otherwise specified, commercial 
preparations were used without further recrystallizafion.  "Roche" preparations were recrystal- 
lized two to four times, unless otherwise  specified. Chemical  and chromatographic analyses 
were performed with all preparations and lots used. 
DNP-Protdn  Conjugates.--Dinitrophenyl-bovine T-globulin,  dinitrophenyl-human serum 
albumin, and dinitrophenyl-guinea  pig serum were prepared as described elsewhere (11). These 
conjugates had the following degrees of substitution: DNP13-BGG,  13 x, DNP/1.6  X  10 s g 
BGG; DNP17-HSA, 17 u DNP/O.7 X  105 g HSA; DNP18-GPS, 18 x, DNP/i05 g GPS protein. 
Chromatographic and Chemical Analyses of the DNP-Amino Acid Preparations.--All prep- 
arations tested were subjected to thin layer chromatography in the dark on silica gel plates. 
Thin layer plates were developed for all DNP preparations in at least three solvent systems, 
but in most instances six to eight solvent systems were used. These solvent systems permitted 
the  separation  of  the  DNP-amino  acid  to  be  examined  from  the  internal  standards 
used  (DNFB, DNOH,  DNPNIt~). The chromatograms were examined  under daylight and 
ultraviolet light. For staining we used the chiorobenzidine method of Reindel and Hoppe (12), 
and for nitro groups, a reagent consistingof dimethylaminobenzaldehyde  and stannous chloride 
(13). As controls for possible  impurities, DNOH, DNPNI-I2, and DNFB were added in various 
amounts (0.1-1/~g) to the compound being examined. The sensitivity  limit for these substances, 
under the experimental conditions used, was 0.05-0.1/zg.  Thin layer chromatography was also 
used to detect possible sodium fluoride impurities, which after staining with the aiizarin-zir- 
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The possible presence of fluorinated impurities and/or inorganic fluorine was also investi- 
gated by microanalytical techniques (15,  16). The titration procedure used had a sensitivity 
limit of 0.06%. 
Ash of the DNP-amino acid preparations was also examined qualitatively for the presence 
of fluorine with the alizarin-fluorine blue-lanthanum complex reaction according to Belcher 
(17). 
A nimals.--White spotted Himalayan guinea pigs of either sex, weighing 300-500 g and orig- 
inating from a closed colony, were used throughout. They were fed on a pellet diet, with addi- 
tional greens and water ad libitum. Rabbits were from a mixed random  stock, weighed 3-3.5 
kg at the start of immunization, and were fed a standard pellet diet. 
Immunization  Procedures.-- 
DNP-amino  adds were used whenever possible as 1% solutions in water. The less soluble 
compounds were dissolved in 1-4% sodium bicarbonate by heating in a water bath at 50°C. 
The standard immunization procedure in guinea pigs consisted in five intradermal injections of 
0.1 ml in the flank adminl.qtered on days 0, 2, 4, 7, and 9 (total dose, 5 rag) without adjuvant. 
Dose-responso curves were established with correspondingly reduced doses. 
DNCB and DNFB were dissolved in an alcohol-saline mixture, and 0.1 ml cont~inlng 0.025- 
100/~g was injected intradermally on days 0, 2, 4, 7, and 9. 
DNOH and DNPNH~ were dissolved in water, and 0.1 ml cont~inlng 1.25-10/~g was in- 
jected intradermally according to the same schedule. 
Eplcu~aneou~ sensitizoJion to DNCB: 0.002 ml of a 50% solution in acetone containing 1 mg 
DNCB was applied with a pipette to the shaved skin of the guinea pigs' necks. The site was 
then covered with adhesive tape, which was left in place for 7 days. 
Rabbits were injected subcutaneously in the footpads with DNP-amino acids in complete 
Frennd's adjuvant (Difco Laboratories, Detroit, Mich.) in doses of 13-20 rag. Several subcuta- 
neous booster injections without adjuvant were administered after 3 and 7 wk. 
Skin Test Procedures.-- 
Intradermal tests tv~k DNP-amino  acids: 0.1 nil of a 1% solution in water orin 1-4% sodium 
bicarbonate (similar to the sensitizing injections) was injected intradermally on the 21st post- 
immunization day, the reactions being read after 6, 18, 24, and 48 hr. A reaction was considered 
positive only when the diameter of the lesion exceeded by 50% or more the average primary 
toxic reaction elicited in normal controls. When DNP-amino acids with particularly high pri- 
malt skin toxicity were tested, lower test concentrations, such as 0.5, 0.3, or 0.1% were used. 
Epicutaneous tests wltk DNCB: 0.025  ml solutions of DNCB in acetone at 0.09, 0.05,  and 
0.03% were applied with a pipette to three skin areas of 2 cm  2 each. Such concentrations are 
nontoxic for normal guinea pigs. The contact reactions were evaluated after 24 hr according to 
an arbitrary scale from 0 to 3, described previously (11). The average degree of contact sensi- 
tivity is given by the arithmetic mean of all reactions of an animal group. 
Detection and Ckaracteriza~ion of Anti-dinitropkenyl Antibodies.--Guinea  pigs were bled by 
cardiac puncture 14 days after the first injection of DNP-amino acid, i.e. before any testing, 
and again on day 22, i.e. 1 day after the epicutaneous and intradermal tests. Anti-dinitrophenyl 
antibodies were determined by immunodiffusion and by passive cutaneous anaphylaxis. Im- 
munodiffnsion was performed on microslides or in agar Petri dishes according to Pepys et al. 
(18), using DNP17-HSA as antigen at the standard concentration of 5 mg/mL 
For PCA, sera were diluted 1:5 in 0.01 ~ phosphate-saline, and 0.1 ml was injected intra- 
dermally in two or three normal guinea pigs. The intravenous challenge was performed after 
20-24 hr with 0.5 ml of DNPI~-HSA containing approximately 2 mg of conjugate and 0.5 ml 
2% Evans blue. The diameter of blueing reactions was recorded after 20-30 rain. 1126  ~OGENICITY  O~  DNP-AMINO  ACIDS 
Rabbits were bled on the 14th post-immunization day and repeatedly after different series 
of booster  injections  up to the 70th day. Antibodies  were looked for by immunodiffusion,  PCA, 
and direct precipitation in solution. Immunodiffusion  was performed in agar Petri di.~hes (18) 
and on microslides  with DNP17-HSA as antigen at concentrations varying between 0.1 and 3 
mg/ml. Precipitation and specific  inhibition curves established with DNP17-HSA as antigen 
were determined  spectrophotometrically  according  to the technique  of Eisen (19). PCA studies 
with rabbit sera were performed  as described  above. 
Systemic Anaphylaods.--Guinea  pigs  were  injected intravenously  with 0.5 ml/kg of DNPla- 
BGG on day 22, i.e. 1 day after the epicutancous  and intmdermal tests. 
RESULTS 
Immunogenicity of DNP-Amlno Acids and DNP Derivatives in Guinea Pigs; 
Screening Results.--All compounds studied are listed in Table I. A preparation 
was considered to be immunogenic when it induced either immediate or delayed 
type  hypersensitivity.  Among  35  DNP-amino  acids  and  DNP  derivatives 
studied,  17  induced  both  immediate  and  delayed  hypersensitivity;  8  only 
delayed hypersensitivity; and 10 were not immunogenic. 
Most compounds were studied repeatedly on groups of four to eight guinea 
pigs. Results obtained several months apart were always concordant and repro- 
ducible, whether the compounds were immunogenic or nonimmunogenic. 
On the other hand, four DNP-amino acids (Nos. 2, 4, 5, and 10) tested under 
similar  conditions  gave  discordant  results  when  different  lots  of  the  same 
preparation, produced by different manufacturers,  were tested. The possible 
causes of such differences will be discussed below. 
Induction  of Delayed  ttypersensitivity.-- 
Intradermal tests with DNP-amino  acids  were performed on the 21st post- 
immunization  day.  Positive  reactions  consisted  of  red,  indurated  papules 
appearing after 6 hr and reaching a  diameter of 15-20 mm after 24 hr,  sur- 
rounded by an erythematons and edematous zone measuring 25-30 ram. Strong 
reactions often presented central necrosis. After 48  hr the surrounding  edem- 
atous  zone disappeared,  the  necrotic  papule  persisting  for  3-5  days.  The 
induction of this type of response became visible during the sensitizing course; 
the first, second, and third injections caused only weak primary toxic lesions, 
while the fourth and fifth injections provoked strong reactions resembling the 
test performed on the 21st day. 
Contact  reactions  to  DNCB:  Sensitized  animals  showed  strongly  positive 
reactions when tested on the 21st day, i.e. at their first contact with DNCB. 
Induction  of Anti-DNP  Antibodies.-- 
PCA:  Positive reactions  were obtained  with  sera  of sensitized  animals  as 
early as day 14, i.e. before any testing was performed. As the average size of IeP.Ey,  DE VCECK, GELEICK, AND LERGIER  1127 
PCA reactions increased from the first to the second bleeding, the skin tests 
may have had some boosting effect; this, however, was controlled only on al- 
ready primed animals. 
Precipitating antibodies detectable by immunodiffusion could not be found in 
sensitized  guinea pigs. This indicates, according to standards established with 
various  types of  anti-dinitrophenyl  antibodies,  that  the  yield  of  anti-DNP 
antibodies demonstrated by PCA was certainly under 50/~g antibody protein/ 
mi. 
Anaphylactic  shock was observed in  animals  immunized  with  8  out of 25 
DN-P-amino acid preparations, when challenged intravenously with DNP-BGG 
on day 22, i.e. 1 day after the tests. In no case was anaphylactic shock elicited 
with any DNP-amino acid (100 mg/kg intravenously) in animals immunized 
with the corresponding DNP-amino acid or with DNCB. 
Cross-reactivity belween DNP-Amino Acids and DNCB.--In the first series 
of experiments, groups of guinea pigs immunized with a DNP-amino acid were 
tested, as a rule,  with DNCB and with DNP-amino acids other than the one 
used  for  immunization.  Sensitized  animals  cross-reacted  with  many  other 
immunogenic DNP-amino acids and always with DNCB, but not with non- 
immunogenic DNP-axnino acids (with two exceptions,  Nos. 21 and 24). In all, 
25 DNP-amino acids were investigated in this way. 
In another series of experiments, the guinea pigs were sensitized  with DNCB 
and  then  tested with immunogenic  and  nonimmunogenic DNP-amino acids. 
Such animals  cross-reacted with  11 out of the 19 of the immunogenic DNP- 
amino acids so tested, but in one case also with a nonimmunogenic compound. 
Immunogenicity  of DNP-Amino  Acids in R.abbits.--In  rabbits  immunized 
with di-DNP-L-histidine (No. 15c), no anti-DNP antibodies were detected on 
day 14. On day 38, after a course of five booster injections, enough antibody 
was present to be detected by PCA and by immunodiffusion.  The DNP deriva- 
tives of DL-glutamic acid (No. 10b) and S-L-cysteine (No. 8) showed somewhat 
weaker immunogenicity. 
Quantitative Evaluation of the Immunogenicity of DNP-Amino Acids Compared 
to Other DNP Compounds Possibly Present as Impurities.--To ascertain whether 
the  immunogenicity of  the  DNP-amino  acids  studied  might have been due 
to immunogenic impurities with DNP specificity,  we evaluated quantitatively 
in vivo the immunogenicity of DNP-arnino acids in comparison with DNFB, 
DNOH, DNPNH~, and DNP-protein conjugates they could possibly contain. 
Dose-response curves of some DNP-amino  acids for  inducing  and  eliciting 
delayed reactions to the sensitizer itself: Fig. 1 shows that a dear dose-response 
relationship  was  obtained  with  di-DNP-l~-histidine  (No.  15c) for  both  the 
sensitizing  and the eliciting  dose. Similar  curves were obtained with mono-O- 
DNP-L-tyrosine  and  DNP-e-aminocaproic  acid.  Therefore  delayed  hyper- 1128  IMMUNOGENICITY  0~  DNP-AMINO  ACIDS 
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sensitivity to DNP-amino acids is induced by total doses of 50-250 #g, whereas 
the elicitafion of positive delayed reactions  (50 % above controls)  requires  an 
intradermal dose of about 100 Izg. 
Dose-response curves of ~arious DNP-amino acids for eliciting delayed reactions 
in animals sensitized with DNCB (Fig. 2): Such animals tested on day 21 showed 
a clear dose-response relationship for the eliciting doses of immunogenic DNP- 
amino acids.  Nonimmunogeuic amino acids,  DNOH,  and DNPNH~ showed 
reactions similar  to those of the nonsensitized  controls. 
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FIG.  1.  Dose-response curves of di-DNP-L-hisfidine (No. 15a) for immunization and intra- 
dermal testing in guinea pigs. 
Immunogenicity  of DNP-amino acids compared to that of DNFB for inducing 
contact sensitivity  to DNCB:  Fig.  3  shows that di-DNP-L-hisfidine  (No.  15a 
and  c),  as  well as  mono-O-DNP-L-tyrosine  and  DNP-¢-aminocaproic  acid, 
regularly induced a dose-dependent  contact sensitivity to DNCB  (score, 1.0- 
2.0) with total doses varying between 50 and 250 #g. DNFB induced the same 
degree of contact sensitivity in doses of 1-2.5 #g, but no contact sensitivity was 
obtained with DNOH  and DNPNI-I~ at doses of 10-50 #g. With DNBSOs, 
doses of 5000 t~g were necessary. DNP-protein conjugates did not induce con- 
tact sensitization to DNCB. 
Immunogenicity  of some DNP-amino acids  for inducing anti-DNP antibodies 
compared to that of DNFB and DNP-protein conjugates and related DNP com- 
pounds:  Fig. 4 shows that di-DNP-L-histidine,  mono-O-DNP-L-tyrosine,  and 
DNP-e-amino caprolc  acid in total doses of 500-2500 #g regularly produced 
anti-DNP antibodies demonstrable by PCA. To induce DNP antibodies yield- 1132  r~'~UNOGENICITY  0]~ DNP-AI~rNO  ACIDS 
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FIo. 3. Immunogenicity of various DNP-amino acids for inducing  contact sensitivity to 
DNCB, compared to that of DNFB and related DNP compounds. ©  O, di-DNP-~histi- 
dine (No. 15c); ~--  -~, di-DNP-~-histidine (No. 15a); 13---I-I, O-DNP-L-tyrosine (No. 28); 
~7 .... ~7,  DNP-e-aminocaproic  acid  (No.  3);  •  @,  dinitrofluorobenzene  (No.  36); 
B- --',  dinitrophenol (No. 37); V-.-Y, dinitroaniline (No. 38). ~REY, DE WECK~ GELEICK, AND LERGIER  1133 
ing PCA reactions  of similar intensity, doses of 25-50  #g DNFB  and 25 #g 
DNP-BGG were necessary. No anti-DNP antibodies were produced by DNOH 
and DNPNH2 (total dose, 10-50 #g)  or DNBSOs  (total dose, 5000 #g). PCA 
results from the second  bleeding  on day 22  (after testing)  were  essentially 
similar. 
To investigate whether "nonimmunogenid'  DN-P-amino acids were inactive 
because the dose of 5 X  Img used for screening was too low, the DNP deriva- 
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FIO. 4.  Immunogenicity of various DNP-amino acids for inducing  anfi-DNP  antibodies 
compared to that of DNFB and related DNP compounds. O  O, di-DNP-L-histidine (No. 
15c); ~- - -~, di-DNP-L-hisfidine (No. 15a); []-.-D, O-DNP-~tyrosine (No. 28); V .... ~7, 
DNP-c-aminoc~proic acid (No. 3); •  •,  dinitrofluorobenzene (No. 36);~- -  --~, dinitro- 
phenol (No. 37); V-.-V~ dinitroanillne (No. 38)• 
tires  d  glycine,  I~asparagine,  L-alanine,  DL-methionine, L-proline,  L-serine, 
and glycylglycine were administered at doses of 5  X  3-20  rag. DNP-glycyl- 
glycine induced contact sensitization to DNCB at the total dose of 50 rag, and 
DNP-L-serine  at the dose of 100 mg, but no anti-DNP antibodies were found. 
The other compounds  remained nonimmunogenic even at these higher doses. 
Investigations  on the Role of DNP and Fluorine  Impurities in the Immuno- 
geniclty  of DNP-Araino Adds.--As  shown  by dose-response  curves  (Figs• 3 
and 4), DNFB was usually 20-100 times more active than some of the immuno- 
genie DNP-amino acid preparations•  It therefore became critical to ascertain 
whether the immunogenic activity of DNP-amino acids was not perhaps due to 1134  IMMUNOGENICITY  OF  DNP-AMINO  ACIDS 
traces  of  "unreacted"  DNFB.  Accordingly,  we performed  chromatographic 
analyses of all DNP-amino acid preparations tested and carried out chemical 
microanalyses  to  determine  the  possible  presence  of  abnormal  amounts  of 
fluorine.  The results of these investigations are summarized in Table I. 
Contamination  with DNFB: A number of preparations appeared to be rela- 
tively impure,  containing DNFB in amounts varying between 0.2 % (Nos.  18 
and  19),  0.05%  (No. 4b),  and  less  than 0.02%  (No. 4a).  In all  other cases, 
DNFB  was  not  found  and  was  excluded  at  the  level  of 0.05%.  However, 
from the comparative dose-response curves and in order to explain the immuno- 
genicity of some DNP-amino acid preparations by contamination with DNFB, 
their DNFB content should be of the order of 1-5 %. Furthermore, recrystalliza- 
tion of di-DNP-L-histidine (No. 15c) up to 10 times did not impair its immuno- 
genicity (Fig. 3). We felt, therefore, that  the immunogenicity of most of the 
DNP-amino acid preparations could not have been due to DNFB contamination 
(20). 
Contamination  with DNOtt and DNPNH2: Several preparations  contained 
DNOH  (Nos.  1,  5a,  11,  12a,  and  23),  DNPNH,  (No.  23),  or unidentified 
impurities  (Nos.  1, 4a, 4b,  10b,  15a,  18,  19, 23,  27a,  and  29b). However, we 
found  27  chromatographically  homogeneous  preparations  in  which  DNFB, 
DNOH, and DNPNH2 were not detected and could be excluded at the level 
of 0.05 %. Among these preparations,  18 were found to be immunogenic and 9 
were not.  Furthermore,  when DNOH and DNPNH, were injected according 
to the usual immunization schedule at doses much higher than those possibly 
present as impurities in the DNP-amino acid preparations, no sensitization was 
achieved (Table I  and Fig. 3). DNOH and DNPNH2 were also incapable of 
eliciting  reactions in sensitized animals. 
Contamination with fluorine:  Some preparations contained traces of inorganic 
fluorine formed during the reaction between DNFB and amino acids.  In other 
preparations, organic fluorine was found in the range of 0.19-0.9%. If ascribed 
to a DNFB impurity, such amounts would correspond to 2-9 % contamination 
with DNFB, which was ruled out by the chromatographic data. No relation- 
ship was observed between the content of organic fluorine and immunogenicity: 
some preparations with a high content of fluorine  (Nos. 2a, 4a, and 29b) were 
not immunogenic,  whereas others in which fluorine  was not detected (Nos. 10a 
and 28)  were nevertheless immunogenic. 
Assuming  that  some molecules of DNFB  could carry 2 fluorine  atoms,  a 
proportion  of the reaction product with  amino  acids would be dinitrofluoro- 
phenylamino acids susceptible of further  conjugation.  However, examination 
of several samples of DNFB of different origins by mass spectrography did not 
disclose a second atom of fluorine in the DNFB molecule. Ultimate purification 
was achieved by countercurrent distribution of di-DNP-L-histidine (No. 15c). ]~REY~ DE WECK, GELEICK, AND LERGIER  1135 
This preparation, in which the presence of DNFB could he entirely excluded,  ~ 
was nevertheless as immunogenic as before. 
Photodecomposition and  heat degradation products: It  is  well  known  that 
DNP-amino acids axe sensitive to light (21). The major photodecomposition 
reaction appears to be a  decarboxylation yielding the corresponding N-alkyl- 
dinitroaniline, CO2, and volatile acidic compounds of unknown structure (22). 
Other known degradation products are 4-nitro-2-nitrosoaniHne  and  a  2-sub- 
stituted 6-nitrobenzimidazole 1-oxide (23). The/$-, ~-, and  ~-DNP groups are 
considered to be resistant  to light,  and DNP-peptides  axe more stable than 
a-DNP-amino acids. In order to establish whether photodecomposition or the 
slight  heating  sometimes  required  for  dissolution  would  influence immuno- 
genicity,  di-DNP-L-histidine  and  S-DNP-cysteine dissolved  in  4%  sodium 
bicarbonate were exposed to sunlight or to ordinary daylight for 30 min. Mere 
daylight  did  not  provoke  chromatographic changes. After exposure to sun- 
light, new additional spots were found, which did not correspond to DNOH, 
DNPNI-I2, or DNFB. Upon heating N,O-di-DNP-L-tyrosine in pyridine or 4% 
sodium bicarbonate at 50°C  for 5  hr,  no chromatographic changes were ob- 
served. Light and ultraviolet irradiation of di-DNP-L-histidine did not increase 
its immunogenicity. No sensitization was achieved with ultraviolet-irradiated 
solutions  of  the  nonimmunogenic  DNP-L-proline.  Under  our  experimental 
conditions, therefore, in which the solutions were exposed to ordinary daylight 
for less than 30 rain, no major changes occurred. 
DNP-protein contaminants: Di-DNP-L-histidine (No. 15b) was analyzed for 
DNP-protein impurities. Ultracentrifugation of an aqueous extract showed that 
possible  water-soluble impurities  amounted  to less  than  0.02%.  Di-DNP-L- 
histidine dissolved in aqueous 1% bicarbonate solution tended to form miceUes, 
whereas it behaved as a single homogeneous substance in dimethylformamide. 
The same preparation (No.  15b), when subjected to column chromatography 
on Sephadex G-25, showed no front peak with ultraviolet absorption at 360 
urn, and the presence of DNP-protein impurities could accordingly be excluded 
at the 0.01% level. These findings rule out the possibility that undetected DNP- 
protein impurities carried along during the manufacturing process could have 
been responsible for the immunogenic activity of di-DNP-L-histidine. 
Countercurrent  Distribution  of  Di-DNP-L-histidine (No. 15b).--Di-DNP-L-histidine 
(4.0 g) was distributed between the phases of a system consisting of 0.1 ~ aqueous NaHCO3 
(the pH adjusted to 7.6 with HC1) and toluene, 1:1, in a Craig distribution train operating with 
10 ml of each phase per tube. After 100 transfers the di-DNP-L-histidine  was distributed over 
the first 15 tubes. The impurities (0.95%), with a mean K (partition coefficient)  of 0.1, were 
found by residual weight analysis in a broad peak from tubes 70 to 100. By taking K ~  6.1 
as a basis for calculation,  less than 10--90% of the separated material was left with the puri- 
fied di-DNP-L-histidine in the first 14 tubes. DNFB, which travels with K ~  13, was  not 
found under these conditions. 1136  IMMUNOGENICITY  OY  DNP-~O  ACIDS 
Possible influence of the solvent on immunogeni¢ity:  The fact that most DNP- 
amino acids were dissolved in 2--4% sodium bicarbonate does not appear to play 
a role. The immunogenicity of di-DNP-L-histidine and O-DNP-L-tyrosine dis- 
solved in 24%  bicarbonate was compared with that of the same substances 
dissolved in dimethylformamide. Upon testing the animals with different doses 
ranging from 1000  to  10 pg,  similar dose-response  curves were  obtained  for 
each compound regardless of the solvent used for immunization. 
Differences  in the Immunogenicity of  Various Lots of the Same DNP-Amino 
Add.--With four DNP-amino acids, DNP-L-alanine (Nos. 2a and 2b), DNP- 
L-asparagine (Nos.  4a  and 4b),  DNP-L-aspartic  acid  (Nos.  5a and 5b),  and 
DNP-DL-glutamic acid (No. 10ad), sensitization was achieved with a lot pur- 
chased from one manufacturer (Mann), whereas the same compound supplied 
by others (British Drug Houses and Sigma) was inactive  (Tables  I  and  ID. 
Cross-testing with different lots of the same substance showed that only im- 
munogenic lots were able to elicit reactions. 
TABLE II 
lmmunogenlvity of Different Lots of tke Same DNP-Amino Acid Preparation; Correlation witk 
Chromatograpk#, and Microanalytical Data 
Compound 
2a. DNT-L-alanine 
2c. DN'P-~-alanine§ 
2b. DN'P-L-alanine 
~a. DNP-~-asparagine 
4b. DNP-T.-asparagine 
5a. DNP-L-aspartic acid 
5b. DNP-y~-aspartic acid 
0a. DNT-nL-giutandc acid 
0b. DNP-DL-glutamIc acid 
0c. DNP-n~-glutamic acid 
0d. DNP-DL-glutamic acid 
Origin 
BDH 750572 
BDH 045000 
Mann S 1105 
BDH 2982910 
Mama J  199o 
BDH 2982900 
Mann S 3683 
BDH 2982930 
Mann S 1107 
Mama T  1269 
Sigma 77B 
Immunogenicity* 
Ab  CS  DR 
0/8  4/24  0/24 
o/s  o/8  o/s 
16/16  20/20  20/20 
o/e  o/12  o112 
4/4  8/8  o/8 
0/4  I/4  0/4 
4/4  7/8  7/8 
o/15  ui28  5/28 
17/20  24/24  .23/24 
3/12  27/27  1.2/27 
0/20  0/27  0/27 
rized 
results 
(+) 
++ 
++ 
++ 
(+) 
++ 
+ 
Thin layer 
chromatography 
Homogeneous~ 
Homogeneous 
Homogeneous 
Impurities~ 
Impurities 
Impurities 
Homogeneous 
Homogeneous 
Impurities 
Homogeneous 
Homogeneous 
Fluorine 
content 
Or-  Inor- 
ganic  ganic 
l__ 
%  i 
0.3  + 
0.4  I  + 
0.3  (+) 
0.9  ++ 
i 
<0.05 !  (+) 
0.4  [  -- 
0.4  :  + 
<0.07  I  -- 
s Ab -  anti-D~P antibody; CS ffi contact sensitivity to DNCB; DR =  delayed reaction to DNP-amlno acid: ex- 
pressed as in Table I. 
DNFB, DNOH, and DNTNHt <0.05%. 
§ Not included in Table I. 
U  DNFB <0.05%; one or two unidentified additional spots. 
As  each lot certainly contained the stated DNP-amino  acid, the variable 
immunogenicity and eliciting capacity of different lots of the same compounds 
most probably was due to a highly immtmogenic impurity rather than to the 
DNP-amino acid itself. If the DNP-amino acid itself were immunogenlc, cross- FREY, DE V~ECK, GELEICK, AND LERGIER  1137 
reactions  between  various  lots  would  be  expected.  Chromatographic  and 
chemical analyses of these preparations were therefore of critical importance 
for the interpretation  of the results.  From the data presented in Table II,  a 
conflicting picture emerges. In the case of DNP-DL-glutamic acid, the immuno- 
genic lot from M~nn~ S 1107, certainly appeared somewhat impure (chromato- 
graphic heterogeneity, higher content in organic fluorine)  in comparison with 
the  nonimmunogenic  lots  from  British  Drug  Houses and  Sigma.  However, 
strlk{ng  differences  in  immunogenicity  were  observed  between  chromato- 
graphically identical preparations,  and no relationship  to the fluorine  content 
could be established. 
The differences in {mmunogenicity among various lots were verified not to be 
due to genetic differences  among our guinea pigs.  Guinea pigs injected with a 
nonlmmunogenic  lot of DNP-L-alanine were subsequently  sensitized without 
difficulty with an immunogenic lot of the same DNP-amino acid. 
Potentiation of the Immunogenicity of DNFB by DNP-Amino Acids, Fluorides, 
or Freund's Adjuvant--It  often appeared impossible,  on the basis of chroma- 
tographic data, that the immunogenicity of a given DNP-amino acid lot could 
have been due to contamination with unreacted DNFB. However, it could not 
be excluded a priori that some impurity or the nonimmunogenic DNP-arnino 
acid itself might potentiate the immunogenic  effect of undetectable traces  of 
DNFB (e.g. due to an unspecific inflammatory effect in the skin). Accordingly, 
we injected some animal groups intradermaUy with small amounts of DNFB 
(5 X  4/~g) mixed with increasing  amounts (S X  10-1000/~g)  of a nonimmuno- 
genie  DNP-amino  acid  such  as  DNP-L~valine.  No  potentiation  effect was 
noticed. The addition of sodium fluoride or ammonium fluoride in doses of 5 X 
1-1.25 mg to immunogenic and nonimmunogenic lots of DNP-DL-glutamic acid 
did not modify this immunogenicity. 
The  incorporation  of DNFB  or di-DNP-n-histidine  in  complete Freund's 
adjuvant  (one single  injection)  had  a  marked  effect upon the  induction  of 
delayed and contact hypersensitivity to DNCB: the immunogenicity threshold 
was lowered for DNFB to 1/zg, and for di-DNP-L-histidine to 10 ~g. On the 
other hand,  incorporation  in complete Freund's  adjuvant  did not lower the 
immunogenicity  threshold  as  far  as  PCA-active  anti-DNP  antibodies  were 
concerned. 
Production of Immunogeniv DNP Conjugates upon Invubation of Di-DNP-L- 
histidine  with  Bovine T-Globulin In  Vitro.--As  the  immunogenicity  of  di- 
DNP-L-histidine was not modified by repeated crystallization up to 10 times or 
by exclusion of DNFB impurities by countercurrent distribution, we decided to 
check whether di-DNP-L-histidine could perhaps form immunogenic conjugates 
with a carrier protein when incubated in vitro. Accordingly, 100 mg di-DNP-T.- 
histidine 10 times recrystallized were incubated with 100 mg BGG in 10 ml 0.01 
phosphate-saline for 24 hr at 37°C in the dark. Mter incubation, the mixture 1138  IMlwUNOGENICITY  OF DNP-AMIN0  ACIDS 
was chromatographed on a Sephadex G-25 column, and the first peak contain- 
ing the protein was collected. In a control experiment, di-DNP-L-histidine was 
incubated under the same conditions except that BGG was only added im- 
mediately  prior  to  chromatographic  separation.  From  spectrophotometric 
analysis and from the ratio  of optical densities at  360  nm,  it  could not be 
ascertained whether conjugation had taken place in the incubated sample. The 
slight difference in As~o:A~  ratio observed amounted to less than 0.5  DNP 
group/molecule BGG in the incubated sample. However, when both protein 
0~o 
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Fro. 5.  Inhibition  of  precipitation  of  anti-DNP  antibodies  by  di-DN£-L-hisitidine  and 
DNP-e-aminocaproic acid. Shown is the precipitation of rabbit anti-DNP-BGG antibody 
(  ) and rabbit anti-di-DNP-L-hisfidine  antibody (- - -) by di-DNP-L-histidine (V) and 
DNP-~-aminocaproic acid (©). 
samples  were  used  to  immunize guinea  pigs,  it  became  evident that  BGG 
incubated for 24 hr with di-DNP-T.-histidine was able to induce the formation 
of DNP-specific antibodies whereas BGG merely mixed with di-DNP-L-histidine 
prior to chromatographic separation could only induce antibodies with BGG 
specificity. None of the protein samples could precipitate anti-DNP antibodies 
or elicit allergic reactions of DNP specificity in animals immunized with other 
DNP-proteins  (e.g. DNP-HSA). 
Specificity  of Rabbit Precipitating  Antibodies  Induced by Di-DNP-L-histidine. 
--As rabbits injected with di-DNP-L-histidine formed antibodies which could 
be  precipitated  by  various  DNP-protein  conjugates  (e.g.  DNPlr-HSA),  it 
became possible to assess  the specificity of such  antibodies by precipitation ~REY, DE WECK~ GELEICK, AND LERGIER  1139 
inhibition.  DNP17-HSA  precipitated  about  150  #g  antibody  protein/ml  in 
the best anti-di-DNP-L-histidine sera. A 7-globuiin fraction prepared by am- 
monium  sulfate precipitation  (24)  was compared  with  one  containing  anti- 
bodies induced in rabbits by DNP-BGG. Antibody concentrations  were ad- 
justed  to  obtain  approximately  equal  amounts  of  precipitate  with DNPI~- 
HSA  at  equivalence,  and  various  amounts  of DNP-¢-aminocaproate  or  di- 
DNP-L-histidine  were added for specific inhibition.  The results are shown in 
Fig. 5. 
Since the DNP-BGG conjugate serving for immunization had been prepared 
with dinitrobenzenesulfonic acid (11),  the antigenic determinants were almost 
exclusively  of  DNP-E-L-lysyl  specificity.  ¢-DNP-lysine  and  ¢-DNP-~mlno 
caproate appeared to be the best inhibitors for the precipitation of such anti- 
bodies. It is noteworthy that antibodies induced by di-DNP-L-histidine showed 
a  very similar  inhibition  pattern,  DNP-¢-aminocaproate  being  a  better  in- 
hibitor than the immunizing DNP-amino acid itself. 
DISCUSSION 
The present investigation  was undertaken in order to ascertain whether 
molecules as small as DNP-amino acids are able to function as immunogens. 
From an operational point of view, we found that numerous I)NP-amino acids 
can induce delayed and/or immediate type hypersensitivity of DNP specificity. 
Among 35 DNP-amino acids or DNP derivatives studied, 10 were found to be 
nonlmmunogenic,  15  were irregularly immunogenic  (erratic sensitization  and 
variations from one preparation lot to another), and 10 were always immuno- 
genic, even despite extensive recrystaUization and purification. 
Before being able to interpret  these findings,  we had to establish that the 
immune response was indeed induced by the DNP-amino acid molecule itself 
and not by some immunogenic impurity of DNP specificity carried along during 
the manufacturing  and purification procedures. 
The irregular  immunogenicity of numerous DNP-amino  acid preparations 
could theoretically be explained by the presence of small amounts of unreacted 
DNFB able to form DNP conjugates in vivo. This would be compatible with 
(a)  the extensive cross-reactivity among immunogenic DNP-~mino acids and 
DNCB,  (b) the requirement for relatively high doses of DNP-amino acids in 
comparison to DNFB, and  (c)  the fact that  a  few DNP-amino  acids--non- 
immunogeuic  at  the  dose of  5  rag--became  immunogenic  when  injected  in 
higher amounts. On the other hand, chromatographic and microanalytical data 
are incompatible with the assumption that DNFB could be the impurity re- 
sponsible for DNP-specific sensitization induced by several DNP-amino acid 
lots. In most instances,  the dose-response curves obtained could only be ex- 
plained by a 1-5 % DNFB impurity, which would certainly have been detected 
by chromatography. The immunogenicity of such chromatographically "pure" 1140  ]-~/UNOGENICITY  OF  DNP-AMINO  ACIDS 
DNP-amino  acids  therefore  has  to  be  explained  either  by  potentiation  of 
~mmunogenlc DNFB  traces,  by unknown factors, or by another undetected 
and highly immunogenic impurity with DNP  specificity. The fact that im- 
munogenic and nonimmunogenlc lots of the same DNP-amino acid could not 
be distinguished analytically leads us to conclude that criteria of purity usually 
accepted in analytical chemistry may be insufficient for the interpretation of 
immunochemicai data. 
However, in the instances of DNP-amlno acids whose immunogenicity was 
constant from one preparation lot to another and was not impaired by repeated 
recrystallization  and  other  purification  procedures  such  as  countercurrent 
distribution, it appears much more likely that the DNP-amino acid itself was 
responsible for sensitization. This is practically certain for di-DNP-L-histidine, 
which we studied most extensively. What is the fate of a DNP derivative such 
as  di-DNP-L-histidine in  vivo,  and  in  what molecular form does it  induce 
sensitization? Does the DNP-amino acid act as such on the immunocompetent 
cell, or only after binding in some way with an autologous protein? The theoreti- 
cal possibility that a DNP-amino acid could be used in protein synthesis and 
incorporated into autologous proteins appears extremely unlikely. 
On the other hand, we had to consider the possibility that a "trausconjuga- 
tion" phenomenon occurs, in which the DNP group, after splitting off from its 
amino acid carrier, would attach covalenfly to an autologous protein carrier in 
the same way that DNFB forms conjugates with autologous proteins in vivo. 
The covalent bond between the DNP group and amino acids is classically con- 
sidered to be quite stable, as testified by the wide use of dinltrophenylation for 
structural analysis of proteins. Splitting of the DNP-amino acid bond would 
usually be considered as leading to the formation of dinitrophenol or dinltro- 
aniline, which was found to be nonlmmunogenic in our system. However, the 
possibility that our results with some consistently immunogenlc DNP-amino 
acids could have been due to transconjugation gained some credibility from the 
observation  that  extensive cross-reactions  occur  between DNCB  and  these 
DNP-amino  acids. Furthermore, we have shown that antibodies induced by 
di-DNP-L-histidine have a definite specificity for the e-DNP-lysyl determinant. 
If  transconjugation  indeed  occurs,  one  would  expect  the  new  conjugates 
formed in vivo to possess mostly e-DNP-lysyl specificity, as is the case for anti- 
bodies induced in vivo by DNCB or DNFB. 
Some direct chemical evidence for transconjugation was reported recently by 
Shaltiel (25),  who demonstrated that S-DNP-cysteine, O-DNP-tyrosine,  and 
N-DNP-histidine readily react under mild conditions with sulfhydryl reagents 
such as 2-mercaptoethanol to yield a DNP-mercapto derivative and the original 
amino acid. In this connection, it is striking to note that DNP-amino acids in 
which the DNP group is bound to a sulfur or an oxygen atom, or to a tertiary 
amine function, are precisely those which are most strongly and consistently I~REY) DE V/ECK) GELEICK, AND LERGIER  1141 
/mmunogenic (Table I), and that a  compound like DNP-l-pipetidine carbo- 
dithioate, in which the DNP group is bound to a non-~mluo acid cartier through 
a sulfur atom, is also immunogenic. Finally, it appears from our dose-response 
curves that compounds such as S-DNP-L-cysteine, O-DNP-L-tyrosine, or di- 
DNP-L-cystine  are  even  more  immunogenic than  some  DNP  compounds 
definitely able to conjugate in vivo, e.g.  dinitrobenzenesul/onic acid.  Further 
evidence compatible with a transconjugation hypothesis is also obtained from 
our  experiment in  which an immunogenic DNP  conjugate was  apparently 
formed in vitro upon incubation of di-DNP-L-histidine with BGG.  Although 
this result does not constitute final evidence that transconjugation took place, 
mere adsorption appears unlikely to account for the immunogenic effect. The 
control experiment in which BGG was not incubated, but merely mixed with 
di-DNP-T.-histidine  prior to chromatographic separation, was negative. 
We are therefore of the opinion that in the case of irregularly immunogeuic 
DNP-amlno  acids  we  are  certainly  dealing  with  immunogeuic impurities, 
whereas a  transconjugation phenomenon may well account for the imrnuno- 
genicity of several regularly immunogenic DNP-~rnlno acids. 
Accordingly, the possibility that the hapten-amlno acid molecule as s~h 
could exert its immunogenic effect on the antigen-sensitive cell appears rather 
remote. The reports postulating {mruunogenicity of a few hapten-~mluo acids 
(e.g. DNP-amlno adds, i~-azobenzene arsonate-tyrosine) are to be balanced 
with numerous negative observations. As our experience shows,  usually ac- 
cepted criteria of chromatographic purity are insufficient to ascertain that the 
compound designed as {mmunogenic is really responsible  for the sensitization 
observed. Accordingly, we feel that  the evidence presented by some other 
groups pointing to the immunogenicity of hapten-amino acids (5, 7, 8) has to 
be reevaluated, as in several instances the doses used for immunization, espe- 
cially when incorporated in complete Freund's adjuvant, were sufficient on the 
basis of our experience with DNP-amino acids to attribute the results to some 
highly immunogenic  impurity. In experiments dealing with the imrnunogenicity 
of hapten-~mluo acids, a systematic use of dose-response curves appears to be 
required, and control experiments involving incubation of the alleged compound 
with proteins in vitro should be followed by immunization with such proteins 
in  order to  exclude that  significant conjugation or "transconjugation" has 
taken place. 
SlY~r~d~Y 
Numerous  dinltrophenyl amino  acid  preparations  injected  intradermally 
induced contact hypersensitivity to  dinltrochlorobenzene, delayed type  skin 
reactions  to  DNP-amlno  acids,  and  anti-DNP  antibodies  in  guinea  pigs. 
Some DNP-~mh~o acids induced precipitating anti-DNP antibodies in rabbits as 
well. 1142  IMMUNOGENICITY  OF  DNP-AMINO  ACIDS 
Some of the DNP-amino acids studied were regularly immunogenic, possible 
immunogenic impurities having been excluded  by extensive purification pro- 
cedures.  Others  were  either  constantly  nonimmunogenic  or  irregularly  im- 
munogenic,  e.g.,  their  immunogenicity varying from  one  preparation  lot  to 
another. 
By means  of  extensive  chemical  analyses  and  the  establishment  of  dose- 
response curves, we were able to demonstrate in most cases that the immuno- 
genicity was not due to contamination with unreacted  dinitrofluorobenzene or 
other DNP derivatives, to photodecomposition or other degradation products, 
or to DNP-protein contaminants. Nevertheless, the irregular immunogenicity 
of several DNP-amino  acid  preparations  can  only be explained by a  highly 
immunogenic impurity (or impurities) which we were unable to detect analyti- 
cally. 
The regular immunogenicity of some other DNP-amlno acids (e.g. di-DNP- 
L-histidine)  appears  to  be based  on  a  "transconjugation"  phenomenon,  the 
DNP group being able to split off from its amino acid carrier and to conjugate 
secondarily with proteins in vivo and in vitro. Accordingly, the interpretation 
of some recent data concerning the immunogenicity of low molecular weight 
hapten-amino acids may have to be reevaluated. 
We are indebted to Dr. K. H. Berneis for ultracentrifugal analysis, to Dr. A. DirscherI for 
microanalytical determination of fluorine, to Mr. P. Lanz for the synthetic preparation of some 
DNP-amlno  acids, to  Dr.  A.  Lutz  for  the  synthesis  of  4-nJtro-2-nitrosoanfllne, to  Dr. 
K. Pfoertner and Mr. D. B6se for the preparation of light degradation products, to Dr. C. H. 
Schneider for countercurrent distribution analysis, and to Dr. K. Vogler for chemical advice. 
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